基于m6ARNA修饰的肝细胞癌的预后生物标志物的鉴定

Jiachun Sun1, Ziyi Xu1, Yitao Fan1

  • 1Henan Key Laboratory of Cancer Epigenetics, Cancer Institute, The First Affiliated Hospital, College of Clinical Medicine, Medical College of Henan University of Science and Technology, Luoyang, Henan, China.

概括

这项研究确定了N6-甲基氨酸 (m6A) RNA修饰生物标志物,用于肝细胞癌 (HCC) 的预后. 一个开发的风险模型有效地区分高风险的HCC患者,有助于个性化治疗策略.